To study the effect of pumpkin seed consumption in the management of Type 2 Diabetes Mellitus.
Phase 3
- Conditions
- Health Condition 1: E119- Type 2 diabetes mellitus without complications
- Registration Number
- CTRI/2024/05/067825
- Lead Sponsor
- Faculty of Ayurveda
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Fasting plasma glucose more than or equal to 126 mg/dl
2 hr plasma glucose more than or equal to 200 mg/dl
HbA1c between 6.5 to 10%
Patient not in the condition of acute illness
Exclusion Criteria
Patient with T1DM or any other kind of diabetes.
Patient having HbA1c more than 10%.
T2DM patient aged below 30 and above 70 years.
T2DM women with pregnancy.
T2DM patient with any other critical condition such as liver or kidney infections.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To assess the efficacy of whole pumpkin seed powder in lowering the mean plasma <br/ ><br>glucose level in Type 2 Diabetes mellitus patient.Timepoint: 90 days
- Secondary Outcome Measures
Name Time Method 1.To assess the safety of whole pumpkin seed powder in Type 2 Diabetes mellitus patient. <br/ ><br>2. To assess the change in lipid profile of the patients of T2DM at the baseline and after the completion of the intervention period. <br/ ><br>3. To assess the change in the Liver and Kidney function tests of the T2DM patient before and after completion of the Intervention period.Timepoint: 90 days